EP300‐Mediated MTF1‐K218 Lactylation Buffers AR‐Driven Copper Overload to Suppress Cuproptosis in Castration‐Resistant Prostate Cancer
Advanced Science · 2026-11 · 13 (61)
DOI: 10.1002/advs.77110 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 11.08.2026. Verfasst von Kai Li und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Jiangsu Key Laboratory of Urological Disease Prevention and Treatment, The Second Affiliated Hospital of Nanjing Medical Unive…. Hauptthemen laut MEDLINE: Copper, Cuproptosis, Prostatic Neoplasms, Castration-Resistant, Receptors, Androgen. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific Research Project of Jiangsu Provincial Health Commission, National Natural Science Foundation of China.
Abstract (Originalsprache)
Inducing cuproptosis for cancer therapy currently relies on supraphysiological copper or copper ionophores. Although serum copper is elevated in patients with prostate cancer, whether this is sufficient to trigger physiological cuproptosis remains unclear. Here, we show that tumor copper levels positively correlate with androgen receptor (AR) activity, and castration‐resistant prostate cancer (CRPC) with hyperactivated AR exhibits pathological copper accumulation. AR activation enhances copper uptake while simultaneously conferring tolerance to copper toxicity, creating a buffered copper state. This adaptive response is mediated by metal‐responsive transcription factor 1 (MTF1), which is transcriptionally upregulated by AR and undergoes EP300‐dependent lactylation of lysine 218, promoting copper‐induced nuclear translocation. Nuclear MTF1 activates metallothioneins (MT1E, MT1F, and MT1M) that sequester cytosolic copper and restrict mitochondrial copper accumulation. Disrupting MTF1 collapses this buffering system, enabling endogenous copper to trigger cuproptosis and suppress CRPC growth. These findings identify cuproptosis as a therapeutically exploitable vulnerability in CRPC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Jiangsu Key Laboratory of Urological Disease Prevention and Treatment, The Second Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing, China.
- Department of Urology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
- Jiangsu Key Laboratory of Intelligent Medical Image Computing, School of Artificial Intelligence, Nanjing University of Information Science and Technology, Nanjing, China.
- Digital Medical Research Center, School of Basic Medical Sciences, Fudan University, Shanghai, China.
- Shanghai Key Laboratory of Medical Image Computing and Computer Assisted Intervention, Fudan University, Shanghai, China.
- Department of Urology, Jiangnan University Medical Center, Wuxi, China.
ORCID-Profile: Kai Li, Yong Wei, Mingzhi Yuan, Youjian Li, Ruixi Yu, Jun Xu, Mulong Du, Bing Yao, Qingyi Zhu
Förderung
- Scientific Research Project of Jiangsu Provincial Health Commission
- National Natural Science Foundation of China
Zitieren
APA
Li, K., Wei, Y., Li, Y., Dong, Y., Lv, J., Yuan, M., Shen, A., Liu, F., Zhang, Y., Li, Y., Yu, R., Liu, Y., Zhao, T., Wang, J., Zhou, K., Fan, Z., Wang, M., Xu, J., Du, M., …, & Zhu, Q. (2026). EP300‐Mediated MTF1‐K218 Lactylation Buffers AR‐Driven Copper Overload to Suppress Cuproptosis in Castration‐Resistant Prostate Cancer. Advanced Science, 13(61). https://doi.org/10.1002/advs.77110
Vancouver
Li K, Wei Y, Li Y, Dong Y, Lv J, Yuan M, et al. EP300‐Mediated MTF1‐K218 Lactylation Buffers AR‐Driven Copper Overload to Suppress Cuproptosis in Castration‐Resistant Prostate Cancer. Advanced Science. 2026;13(61). doi:10.1002/advs.77110
BibTeX
@article{Li2026,
author = {Li, Kai and Wei, Yong and Li, Yongshan and Dong, Yuxiang and Lv, Jiancheng and Yuan, Mingzhi and Shen, Ao and Liu, Fuyang and Zhang, Yetao and Li, Youjian and Yu, Ruixi and Liu, Yang and Zhao, Tong and Wang, Jun and Zhou, Kai and Fan, Zongyao and Wang, Manning and Xu, Jun and Du, Mulong and Gu, Min and Yao, Bing and Zhu, Qingyi},
title = {EP300‐Mediated MTF1‐K218 Lactylation Buffers AR‐Driven Copper Overload to Suppress Cuproptosis in Castration‐Resistant Prostate Cancer},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {61},
doi = {10.1002/advs.77110}
}
EUVIMED